Sami Karaborni

Drug Development

Sami Karaborni, PhD is an expert in product and process development of new chemical entities (NCEs) and various dosage forms. Over his 30-year career he served in several senior executive positions including Vice President of Development Operations and Executive Director of Preformulation and Formulation Development at XenoPort Inc. At XenoPort, he led multiple groups active in the areas of chemical, analytical, bioanalytical, formulation development, supply chain, and commercial manufacturing. He was Director of Pre-clinical Development Technology, Director of Materials Characterization and Technology Assessment, and Director of Formulation Design and Characterization at Merck Research Labs. In his early career, he was Senior Research Engineer for the Royal Dutch Shell company in Amsterdam, The Netherlands.

Sami is a member of the advisory board of the Surfactant Science series and inventor of more than 20 US published patents and patent applications. Sami is the (co)author of more than 40 publications in international journals, including Science (Washington), Nature (London), La Recherche Scientifique (Paris), and Mundo Científico (Madrid). He has been a keynote speaker at several conferences such as which Gordon Conferences (USA), Royal Society of Chemistry (Great Britain) and Rencontres de Moriond (Switzerland).

Sami holds a BS in chemical engineering from Penn State University, an MS and PhD in chemical engineering from the University of Florida, and conducted postdoctoral research in chemical engineering at the University of Virginia.


Roles at Monopteros

  • Drug Development

    Current role

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at Monopteros

My pet peeves

My communication style

Org chart

Direct reports

No reports


No teams